News | March 06, 2014

Valley Hospital Implants Reveal Linq Heart Monitor

Medtronic Reveal Linq Insertable Cardiac Monitor Implantable ECG Wireless EP Lab

March 6, 2014 — The Valley Hospital in Ridgewood, N.J., is among a few hospitals in the nation to implant a tiny wireless heart monitor expected to have impacts for patients and doctors.

Indicated for use as a diagnostic tool for people suffering from unexplained fainting, dizziness, palpitations or shortness of breath, the device can also help doctors determine if a patient has atrial fibrillation, the most common form of heart rhythm abnormality.

Nick Rotonda of Upper Saddle River, N.J., was the first patient to receive the device at Valley and is counting on it to monitor whether he has any signs of atrial fibrillation, which could increase his risk for a stroke.

About one-third the size of a AAA battery and almost 90 percent smaller than similar devices, the Reveal Linq implantable cardiac monitor is slipped just beneath the skin with a syringe-like device through an incision less than half an inch long.  It continuously and wirelessly monitors the heart for up to three years and notifies physicians if patients have significant cardiac events. It is also MRI-compatible.

"It takes about 5 minutes to implant the device using a local anesthetic," said cardiac electrophysiologist Dan L. Musat, M.D., attending physician at Valley's Arrhythmia Institute, part of the Valley Heart and Vascular Institute. "There is no need for general anesthetic, the device is not visible in most patients and patients go home after about an hour," said Musat, who performed Valley's first procedure.

The device has the ability to communicate wirelessly via a small tabletop remote monitoring station while patients sleep, allowing them to continue living their lives normally, even away from home.

"This is one of the most innovative technologies to emerge in cardiology in the last decade," said Suneet Mittal, M.D., director of the electrophysiology lab at Valley. "It is so discreet that most patients will not even know it is there and can go about their lives without interruption or discomfort. It truly is a game changer."

"This monitor gives me peace of mind because I know that if I have an episode it will alert my doctor so he can address it," Rotonda said.

Medtronic's Reveal Linq was approved by the U.S. Food and Drug Administration in February.

For more information:

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init